ASX - By Stock
|
NEU |
Re:
Very little stock for sale
|
|
Noda
|
171 |
112K |
9 |
02/09/19 |
02/09/19 |
ASX - By Stock
|
171
|
112K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Very little stock for sale
|
|
Noda
|
171 |
112K |
3 |
30/08/19 |
30/08/19 |
ASX - By Stock
|
171
|
112K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren advances pipeline for neurodevelopmental disorders
|
|
Noda
|
12 |
11K |
25 |
28/08/19 |
28/08/19 |
ASX - By Stock
|
12
|
11K
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Very little stock for sale
|
|
Noda
|
171 |
112K |
2 |
28/08/19 |
28/08/19 |
ASX - By Stock
|
171
|
112K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Lavender Update
|
|
Noda
|
15 |
10K |
36 |
01/08/19 |
01/08/19 |
ASX - By Stock
|
15
|
10K
|
36
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren submits 3 NNZ-2591 Orphan Drug applications to FDA
|
|
Noda
|
19 |
10K |
5 |
29/07/19 |
29/07/19 |
ASX - By Stock
|
19
|
10K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Acadia Second Quarter Results.
|
|
Noda
|
6 |
5.1K |
10 |
26/07/19 |
26/07/19 |
ASX - By Stock
|
6
|
5.1K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Price Movement
|
|
Noda
|
166 |
104K |
13 |
18/07/19 |
18/07/19 |
ASX - By Stock
|
166
|
104K
|
13
|
|
ASX - By Stock
|
NEU |
Re:
Price Movement
|
|
Noda
|
166 |
104K |
6 |
15/07/19 |
15/07/19 |
ASX - By Stock
|
166
|
104K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Price Movement
|
|
Noda
|
166 |
104K |
10 |
12/07/19 |
12/07/19 |
ASX - By Stock
|
166
|
104K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Goldman Sachs Healthcare Conference
|
|
Noda
|
76 |
32K |
15 |
14/06/19 |
14/06/19 |
ASX - By Stock
|
76
|
32K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Goldman Sachs Healthcare Conference
|
|
Noda
|
76 |
32K |
15 |
13/06/19 |
13/06/19 |
ASX - By Stock
|
76
|
32K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Peanuts
|
|
Noda
|
21 |
15K |
23 |
05/06/19 |
05/06/19 |
ASX - By Stock
|
21
|
15K
|
23
|
|
ASX - By Stock
|
NEU |
Re:
AGM
|
|
Noda
|
38 |
19K |
2 |
30/05/19 |
30/05/19 |
ASX - By Stock
|
38
|
19K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Chairman's Address at 2019 Annual Meeting of Shareholders
|
|
Noda
|
68 |
36K |
9 |
29/05/19 |
29/05/19 |
ASX - By Stock
|
68
|
36K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
AGM
|
|
Noda
|
38 |
19K |
10 |
29/05/19 |
29/05/19 |
ASX - By Stock
|
38
|
19K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Lanstead Selling .
|
|
Noda
|
114 |
57K |
8 |
27/05/19 |
27/05/19 |
ASX - By Stock
|
114
|
57K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Torreya Update
|
|
Noda
|
9 |
6.1K |
3 |
24/05/19 |
24/05/19 |
ASX - By Stock
|
9
|
6.1K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Lanstead just about gone .
|
|
Noda
|
194 |
101K |
4 |
14/05/19 |
14/05/19 |
ASX - By Stock
|
194
|
101K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Lanstead just about gone .
|
|
Noda
|
194 |
101K |
1 |
14/05/19 |
14/05/19 |
ASX - By Stock
|
194
|
101K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Lanstead just about gone .
|
|
Noda
|
194 |
101K |
15 |
14/05/19 |
14/05/19 |
ASX - By Stock
|
194
|
101K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Lanstead just about gone .
|
|
Noda
|
194 |
101K |
8 |
13/05/19 |
13/05/19 |
ASX - By Stock
|
194
|
101K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Lanstead just about gone .
|
|
Noda
|
194 |
101K |
5 |
13/05/19 |
13/05/19 |
ASX - By Stock
|
194
|
101K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Lanstead just about gone .
|
|
Noda
|
194 |
101K |
6 |
10/05/19 |
10/05/19 |
ASX - By Stock
|
194
|
101K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Lanstead just about gone .
|
|
Noda
|
194 |
101K |
6 |
10/05/19 |
10/05/19 |
ASX - By Stock
|
194
|
101K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Lanstead just about gone .
|
|
Noda
|
194 |
101K |
15 |
07/05/19 |
07/05/19 |
ASX - By Stock
|
194
|
101K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Peanuts
|
|
Noda
|
21 |
15K |
21 |
06/05/19 |
06/05/19 |
ASX - By Stock
|
21
|
15K
|
21
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Update on development plan for NNZ-2591
|
|
Noda
|
5 |
4.5K |
9 |
29/04/19 |
29/04/19 |
ASX - By Stock
|
5
|
4.5K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Annual Report to shareholders
|
|
Noda
|
11 |
11K |
6 |
29/04/19 |
29/04/19 |
ASX - By Stock
|
11
|
11K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Annual Report to shareholders
|
|
Noda
|
11 |
11K |
12 |
26/04/19 |
26/04/19 |
ASX - By Stock
|
11
|
11K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Neurology Today
|
|
Noda
|
15 |
8.0K |
7 |
05/04/19 |
05/04/19 |
ASX - By Stock
|
15
|
8.0K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Neurology Today
|
|
Noda
|
15 |
8.0K |
4 |
05/04/19 |
05/04/19 |
ASX - By Stock
|
15
|
8.0K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Exponential Stock Investor
|
|
Noda
|
2 |
2.0K |
2 |
03/04/19 |
03/04/19 |
ASX - By Stock
|
2
|
2.0K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
$4.17-$6.31 Val
|
|
Noda
|
79 |
55K |
4 |
26/03/19 |
26/03/19 |
ASX - By Stock
|
79
|
55K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
$4.17-$6.31 Val
|
|
Noda
|
79 |
55K |
10 |
21/03/19 |
21/03/19 |
ASX - By Stock
|
79
|
55K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
New Pitt Street Report
|
|
Noda
|
7 |
4.2K |
6 |
07/03/19 |
07/03/19 |
ASX - By Stock
|
7
|
4.2K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
SvbLeerink global healthcare conference on Acadia Pharmaceuticals
|
|
Noda
|
18 |
11K |
7 |
04/03/19 |
04/03/19 |
ASX - By Stock
|
18
|
11K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Current Stock Valuation .
|
|
Noda
|
111 |
61K |
11 |
27/02/19 |
27/02/19 |
ASX - By Stock
|
111
|
61K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Ann: NNZ-2591 positive effects in Phelan-McDermid syndrome model
|
|
Noda
|
42 |
29K |
16 |
20/02/19 |
20/02/19 |
ASX - By Stock
|
42
|
29K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
the question is
|
|
Noda
|
9 |
6.0K |
2 |
08/02/19 |
08/02/19 |
ASX - By Stock
|
9
|
6.0K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Plans for Phase 3 trial in Rett syndrome
|
|
Noda
|
102 |
51K |
15 |
05/02/19 |
05/02/19 |
ASX - By Stock
|
102
|
51K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren retains ex-North America, appoints investment bank
|
|
Noda
|
84 |
37K |
21 |
01/02/19 |
01/02/19 |
ASX - By Stock
|
84
|
37K
|
21
|
|
ASX - By Stock
|
NEU |
Re:
ROW Rights
|
|
Noda
|
163 |
83K |
11 |
01/02/19 |
01/02/19 |
ASX - By Stock
|
163
|
83K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
ROW Rights
|
|
Noda
|
163 |
83K |
3 |
30/01/19 |
30/01/19 |
ASX - By Stock
|
163
|
83K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Neuren’s lead work earns US deal via The Australian
|
|
Noda
|
28 |
19K |
11 |
13/12/18 |
13/12/18 |
ASX - By Stock
|
28
|
19K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
Under the Microscope with Dr T
|
|
Noda
|
41 |
22K |
2 |
12/12/18 |
12/12/18 |
ASX - By Stock
|
41
|
22K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Under the Microscope with Dr T
|
|
Noda
|
41 |
22K |
10 |
12/12/18 |
12/12/18 |
ASX - By Stock
|
41
|
22K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Valuation range $4.17 - $$6.31
|
|
Noda
|
27 |
12K |
15 |
06/12/18 |
06/12/18 |
ASX - By Stock
|
27
|
12K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Lanstead selling down.
|
|
Noda
|
86 |
45K |
6 |
03/12/18 |
03/12/18 |
ASX - By Stock
|
86
|
45K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Lanstead selling down.
|
|
Noda
|
86 |
45K |
8 |
03/12/18 |
03/12/18 |
ASX - By Stock
|
86
|
45K
|
8
|
|